Mark DeLong - Chief Business & Strat Officer at Apellis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business & Strat Officer
Stock Symbol
APLS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Mark DeLong - trading volume in the past year for Apellis Pharmaceuticals, Inc.

Holdings reported by Mark DeLong for Apellis Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 14.8K $981K $66.30 Aug 12, 2024 Direct Common Stock
Common Stock 60.4K $836K $13.85 Aug 12, 2024 Direct

Transactions reported by Mark DeLong for Apellis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.